drugset / Trial / NCT00062231

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

NCT00062231

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Antibiotics such as amoxicillin, ciprofloxacin, and moxifloxacin may be effective in preventing or controlling fever and neutropenia in patients with cancer. It is not yet known whether moxifloxacin alone is more effective than amoxicillin combined with ciprofloxacin in treating neutropenia and fever. PURPOSE: This randomized clinical trial is studying how well moxifloxacin works and compares it to ciprofloxacin together with amoxicillin in treating neutropenia and fever in patients with cancer.

Timeline

Start
2002-04
Primary completion
2006-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 750 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral
Subject amoxicillin/clavulanic acid Unknown 1000 mg Oral